Arrowstreet Capital, Limited Partnership Johnson & Johnson Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Johnson & Johnson stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,152,856 shares of JNJ stock, worth $176 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,152,856

Previous 828,116 39.21%

Holding current value

$176 Million

Previous $121 Million 54.36%

% of portfolio

0.15%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$145.48 - $167.38 $47.2 Million - $54.4 Million	324,740 Added 39.21%	1,152,856 $187 Million
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $17.5 Million - $19.2 Million	121,456 Added 17.19%	828,116 $121 Million
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $110 Million - $115 Million	706,660 New	706,660 $112 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $6.47 Million - $7.25 Million	41,553 New	41,553 $6.47 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $63.3 Million - $75.5 Million	418,859 Added 52.64%	1,214,563 $188 Million
Q4 2022 Feb 14, 2023	BUY	$160.2 - $179.79 $113 Million - $126 Million	702,949 Added 757.86%	795,704 $141 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $10.1 Million - $11.3 Million	62,901 Added 210.7%	92,755 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $1.11 Billion - $1.23 Billion	-6,623,756 Reduced 99.55%	29,854 $5.3 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $286 Million - $324 Million	1,805,632 Added 37.25%	6,653,610 $1.18 Billion
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $71.2 Million - $79 Million	-456,414 Reduced 8.6%	4,847,978 $829 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $262 Million - $292 Million	-1,624,375 Reduced 23.44%	5,304,392 $857 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $331 Million - $355 Million	-2,076,227 Reduced 23.06%	6,928,767 $1.14 Billion
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $412 Million - $458 Million	2,688,957 Added 42.57%	9,004,994 $1.48 Billion
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $194 Million - $223 Million	-1,418,237 Reduced 18.34%	6,316,037 $994 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $21.4 Million - $23.5 Million	-152,506 Reduced 1.93%	7,734,274 $1.15 Billion
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $106 Million - $127 Million	819,350 Added 11.59%	7,886,780 $1.11 Billion
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $506 Million - $701 Million	4,551,801 Added 180.94%	7,067,430 $927 Million
Q4 2019 Feb 13, 2020	SELL	$127.5 - $146.44 $30.4 Million - $34.9 Million	-238,661 Reduced 8.67%	2,515,629 $367 Million
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $50 Million - $56 Million	394,185 Added 16.7%	2,754,290 $356 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $19.1 Million - $21 Million	145,426 Added 6.57%	2,360,105 $329 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $148 Million - $165 Million	1,177,416 Added 113.51%	2,214,679 $310 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $124 Million - $150 Million	1,011,263 Added 3889.47%	1,037,263 $134 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $329 Million - $387 Million	-2,705,113 Reduced 99.05%	26,000 $3.59 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $47.2 Million - $52 Million	-395,006 Reduced 12.64%	2,731,113 $331 Million
Q1 2018 May 14, 2018	BUY	$125.1 - $148.14 $284 Million - $336 Million	2,267,727 Added 264.18%	3,126,119 $401 Million
Q4 2017 Feb 09, 2018	BUY	$131.22 - $143.62 $1.84 Million - $2.02 Million	14,039 Added 1.66%	858,392 $120 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $109 Million - $114 Million	844,353	844,353 $110 Million

Others Institutions Holding JNJ

# of Institutions

4,294

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Johnson & Johnson Transaction History